Global Beta-Glucan Market: Overview
Beta-glucans belong to a set of physiologically active compounds called immunomodulation agents. These are compounds that trigger biological events and responses to regulate the immune system, thus making it more efficient to ward off a host of diseases. World over, scores of researches over several decades have confirmed its efficacy in fighting cancer and infections caused by antibiotic-resistant bacteria. Since beta-glucans are not produced naturally, they need to be taken externally, mostly as food additives. Driven by myriad benefits, clinicians increasingly recommend their use as standalone molecules or in combination with other drugs to help the body overcome different cancer types. These molecules can be derived from a wide variety of sources and the choice depends on the availability of the natural resources in a particular region. Most commonly used sources are various species of yeast, mushrooms, grains, and seaweed.
Global Beta-Glucan Market: Key Trends
Rising health consciousness amongst consumers and increasing health spending in various regions have propelled the beta-glucan market. Soaring awareness regarding the cancer-fighting and anti-tumor properties of beta-glucans has accelerated its demand among people worldwide. Growing popularity in some nations has catapulted its use as an immunoadjuvant therapy for cancer. Intense studies on immunological activities of commercially-available beta-glucan and several product enhancement strategies adopted by leading players are expected to catalyze the market growth in the coming years. Increasing application of beta-glucans as yeast additives to help in biodiesel blending and emerging applications in the cosmetics and pharmaceutical industries are anticipated to open up lucrative market avenues over the forecast period.
Global Beta-Glucan Market: Market Potential
Breakthroughs in extraction methods of beta-glucans have led to cost-effective manufacturing processes. In addition, technological advancements have helped several pharmaceutical companies focusing on animal and human nutrition expand their product portfolio across various regions.
Kemin Industries, a global company offering nutritional ingredients for humans as well as animals, announced in March, 2017 the acquisition of a cutting-edge beta-glucan manufacturing technology from Algal Scientific, a company based in Michigan. The purchase will allow the global company to expand its alternative antibiotic portfolio. The acquisition typically involves the assets required to manufacture beta-glucan, including key production facilities and technical expertise of the employees of Algal Scientific. Kemin will exploit this technology to offer a host of advanced gut-health products for animals and humans.
Compared to its earlier yeast-derived beta-glucan technology, the new process is a marked advancement in terms of reduced manufacturing cost, since beta-glucans produced do not involve any extraction process. Furthermore, the highly concentrated products will allow the company to market it as animal feed ingredients to the poultry and pig industry globally. For instance, numerous owners of poultry farms can include beta-1,3-glucan as a part of algae meal for animals. Kemin has plans in place to continue researches in expanding the application of this technology to make further improvements in beta-glucans.
Global Beta-Glucan Market: Regional Outlook
Europe is a prominent market for beta-glucans. The substantial demand for beta-glucans as animal additive and nutraceuticals in this region is driven by favorable governmental regulations and burgeoning functional food and pharmaceutical industries. North America is another region offering lucrative opportunities to manufacturers.
The Asia Pacific market for beta-glucans is anticipated to witness impressive growth over the forecast period. The significant growth of the regional market is attributed to a rapid expansion of the pharmaceutical and nutraceuticals industries and increasing awareness of the numerous disease-fighting benefits of beta-glucans in emerging markets such as India, Thailand, China, and Vietnam.
Global Beta-Glucan Market: Competitive Analysis
The beta-glucan market is somewhat competitive due to increasing threat of forward integration from several yeast suppliers. Owing to significant benefits of economies of scale, yeast suppliers enjoy a competitive edge over others. Several players are making partnerships and collaborations to expand their technological expertise in beta-glucan manufacturing. Companies vying for a sustained share in the beta-glucan market include Cargill, Inc., Tate & Lyle, Kerry Group, Koninklijke DSM N.V., MilliporeSigma, Frutarom Industries Ltd., Garuda International Inc., and Lesaffre Human Care.
The study presents reliable qualitative and quantitative insights into:
The regional analysis covers:
The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.
Highlights of the report:
Note: Immense care has been taken to present data with the highest levels of accuracy in all TMRResearch reports. Nevertheless, recent developments related to market/vendor landscape may take time to reflect in the analysis.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report